학술논문

Sofosbuvir in combination with PEG IFN and ribavirin for 12 weeks provides high SVR rates in HCV-infected genotype 2 or 3 treatment experienced patients with and without compensated cirrhosis: results from the LONESTAR-2 study
Document Type
Academic Journal
Source
Journal of Gastroenterology and Hepatology. Oct 01, 2014 29 Supp. 2:94-94
Subject
Language
English
ISSN
0815-9319